Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
39 hedge funds and large institutions have $35.8M invested in Decibel Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 5 closing their positions.
9,600% more call options, than puts
Call options by funds: $291K | Put options by funds: $3K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 40 → 39 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
20% less capital invested
Capital invested by funds: $45M → $35.8M (-$9.21M)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$523K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$274K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$152K |
| 4 |
E
Ergoteles
New York
|
+$71.5K |
| 5 |
State Street
Boston,
Massachusetts
|
+$54.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$820K |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$737K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$546K |
| 4 |
BlackRock
New York
|
-$249K |
| 5 |
Neuberger Berman Group
New York
|
-$159K |
DBTX Hedge Fund Activity: Q4 2022 in Review
39 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q4 2022, worth a combined $35.8M — down 20% from $45M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of DBTX and 4 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 8 added.
The largest buyer was Millennium Management, adding an estimated $523K. The largest seller was EAM Investors, exiting entirely with an estimated $820K sold.
- 39 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q4 2022, down from 40 in Q3 2022.
- Funds reported $35.8M of Decibel Therapeutics, Inc. Common Stock stock for Q4 2022, down 20% quarter-over-quarter.
- 4 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q4 2022 and 5 closed out, a net change of -1 holder.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q4 2022 was Millennium Management, an estimated $523K added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q4 2022 was EAM Investors, an estimated $820K sold.
Based on aggregated 13F filings for Q4 2022.